Podiatrists in Vega Baja, PR - Medicare Status, Address, Contact

1 Podiatrists found. Showing 1 - 1

Francisco Lopez Hernandez, DPM
Podiatrist - Foot & Ankle Surgery
Medicare: Medicare Enrolled
Practice Location: Baldorioty De Castro 1b, Vega Baja, PR 00693
Phone: 787-858-1935

News Archive

NIH to launch study on Gulf oil spill health effects

The National Institutes of Health will launch a multi-year study this fall to look at the potential health effects from the oil spill in the Gulf region. The Gulf Worker Study, announced by NIH Director Francis S. Collins, M.D., Ph.D., in June, is in response to the largest oil spill in U.S. history, caused by the explosion of the Deepwater Horizon offshore drilling oil rig in the Gulf of Mexico. Dr. Collins pledged $10 million in NIH funding for the study's initial phases.

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company), today announced the availability of the U.S. Food and Drug Administration cleared BD MAX Enteric Parasite Panel for use on the BD MAX System.

NAE and IOM join for panel discussion on 'Engineering Innovations in Healthcare'

WHAT:The National Academy of Engineering (NAE) and the Institute of Medicine (IOM) will join together for the first time at the regional meeting and panel discussion on "Engineering Innovations in Healthcare" at the University of Miami.

Longer looks: Expensive cities for health care; mapping Medicaid

It's bewildering for anyone who has ever paid for a health procedure out of pocket when health insurance doesn't cover the full cost: Why does health care cost the way it does, and why do the costs fluctuate depending on where you go and who you see? A colonoscopy, for example, can range from $500 to $3,000 — a large difference depending on how health insurance providers negotiate rates.

Raptor Pharmaceutical presents positive results from Phase 2a trial of DR cysteamine bitartrate for NASH

Raptor Pharmaceutical Corp., announced positive Phase 2a clinical trial results from its pilot study of delayed-release cysteamine bitartrate in 11 adolescent patients with non-alcoholic steatohepatitis, a progressive form of liver disease believed to affect 5% to 11% of the U.S. population. The results were presented at the Digestive Disease Week 2010 conference in New Orleans, LA on May 2, 2010.

Podiatrists in Vega Baja, PR Accepting Medicare